NIH has recently released stricter conflict-of-interest rules for federally funded researchers in an effort to make sure that their work remains objective, says Forbes' Paul Thacker. But these rules may have never come to be were it not for University of Miami researcher Charles Nemeroff, he adds. Nemeroff was chair of psychiatry at Emory University, while also promoting GlaxoSmithKline's antidepressant Paxil.